Identification Generic Name (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL DrugBank Accession Number DB08224 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL (DB08224) ×  Close Weight Average: 306.3966  Monoisotopic: 306.18310932  Chemical Formula C 18 H 26 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Liver carboxylesterase 1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as delta valerolactones. These are cyclic organic compounds containing an oxan-2- one moiety. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Lactones Sub Class Delta valerolactones Direct Parent Delta valerolactones Alternative Parents Oxanes  /  Secondary alcohols  /  Carboxylic acid esters  /  Oxacyclic compounds  /  Monocarboxylic acids and derivatives  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents Alcohol  /  Aliphatic heteropolycyclic compound  /  Carbonyl group  /  Carboxylic acid derivative  /  Carboxylic acid ester  /  Delta valerolactone  /  Delta_valerolactone  /  Hydrocarbon derivative  /  Monocarboxylic acid or derivatives  /  Organic oxide Molecular Framework Aliphatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key WWSNTLOVYSRDEL-TVKPWXLESA-N InChI InChI=1S/C18H26O4/c1-11-5-6-12-3-2-4-16(20)18(12)15(11)8-7-14-9-13(19)10-17(21)22-14/h3,5-6,11,13-16,18-20H,2,4,7-10H2,1H3/t11-,13+,14-,15-,16-,18-/m0/s1 IUPAC Name (4R,6S)-6-{2-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-hydroxyoxan-2-one SMILES [H][C@]1(O)CC(=O)O[C@@]([H])(CC[C@@]2([H])[C@@]([H])(C)C=CC3=CCC[C@]([H])(O)[C@]23[H])C1 References General References Not Available External Links PubChem Compound 4369567 PubChem Substance 99444695 ChemSpider 3572094 ZINC ZINC000006416565 PDBe Ligand MVB PDB Entries 1ya8 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.26 mg/mL ALOGPS logP 1.73 ALOGPS logP 1.49 Chemaxon logS -3.1 ALOGPS pKa (Strongest Acidic) 14.91 Chemaxon pKa (Strongest Basic) -0.85 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 66.76 Å 2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 85.68 m 3 ·mol -1 Chemaxon Polarizability 33.96 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9372 Blood Brain Barrier + 0.7158 Caco-2 permeable + 0.5949 P-glycoprotein substrate Substrate 0.7746 P-glycoprotein inhibitor I Non-inhibitor 0.8898 P-glycoprotein inhibitor II Non-inhibitor 0.8161 Renal organic cation transporter Non-inhibitor 0.7553 CYP450 2C9 substrate Non-substrate 0.8087 CYP450 2D6 substrate Non-substrate 0.8869 CYP450 3A4 substrate Substrate 0.6044 CYP450 1A2 substrate Non-inhibitor 0.7444 CYP450 2C9 inhibitor Non-inhibitor 0.9514 CYP450 2D6 inhibitor Non-inhibitor 0.9062 CYP450 2C19 inhibitor Non-inhibitor 0.8578 CYP450 3A4 inhibitor Non-inhibitor 0.6102 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.892 Ames test Non AMES toxic 0.8148 Carcinogenicity Non-carcinogens 0.9772 Biodegradation Not ready biodegradable 0.8487 Rat acute toxicity 2.6070 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7194 hERG inhibition (predictor II) Non-inhibitor 0.7995    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Liver carboxylesterase 1 Kind Protein Organism Humans Pharmacological action Unknown General Function Triglyceride lipase activity Specific Function Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs. Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acy... Gene Name CES1 Uniprot ID P23141 Uniprot Name Liver carboxylesterase 1 Molecular Weight 62520.62 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:29 / Updated at June 12, 2020 16:52 